Antimicrobial Agents and Chemotherapy · 2019 · 44 citations · 13 references
MedicinePharmacologyPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyPharmacodynamicsAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntimicrobial PharmacodynamicsBeta-lactam ResistanceCarbapenem ResistanceAcinetobacter Baumannii ResistanceBactericidal AgentsBeta-lactam PharmacodynamicsCarbapenem AntibioticsIn Vivo StudiesMultidrug-resistant Gram-negative BacteriaPharmacodynamic MechanismsResistance Mechanisms In Gram-negative Bacteria
WCK 5222 is a combination of cefepime and the high-affinity PBP2-binding β-lactam enhancer zidebactam. The cefepime-zidebactam combination is active against multidrug-resistant Gram-negative bacteria, including carbapenemase-expressing Acinetobacter baumannii .
13
Krisztina M. Papp‐Wallace, Nhu Q. Nguyen, Michael R. Jacobs et al. · Journal of Medicinal Chemistry · 2018 · 150 citations · Full text
Bartolomé Moyá, Isabel M. Barceló, Sachin Bhagwat et al. · Antimicrobial Agents and Chemotherapy · 2017 · 131 citations
Hélio S. Sader, Paul R. Rhomberg, Robert K. Flamm et al. · Journal of Antimicrobial Chemotherapy · 2017 · 95 citations · Full text
Michael A. Pfaller, Michael D. Huband, Rodrigo E. Mendes et al. · International Journal of Antimicrobial Agents · 2018 · 93 citations